Astrocytes Undergo Metabolic Reprogramming in the Multiple Sclerosis Animal Model

Area of Science:

• Neuroscience
• Immunology
• Metabolic research

Background:

• Multiple sclerosis (MS) is a chronic central nervous system inflammatory disease with an unclear cause.
• Reactive astrocytes are present in MS lesions, but their role in disease pathophysiology remains poorly understood.

Purpose of the Study:

• To investigate astrocyte transcriptome changes and morphology during MS progression using an animal model.
• To explore the link between astrocyte metabolic alterations and disease progression in MS.
• To propose metabolic reprogramming as a novel therapeutic approach for MS.

Main Methods:

• High-throughput sequencing of astrocyte transcriptomes from cerebellum during disease progression in an MS animal model.
• Morphological reconstruction of astrocytes near lesions and in normal-appearing white matter (NAWM) at different disease time points.
• Analysis of gene expression related to metabolic pathways and astrocyte reactivity.

Main Results:

• Astrocytes from the cerebellum showed significant alterations in genes encoding metabolic pathway proteins, including increased glycogen degradation, glycolytic, and TCA cycle enzymes.
• Upregulation of genes associated with astrocyte reactivity was observed.
• Astrocytes near lesions exhibited increased length and complexity compared to controls, with no significant changes in NAWM.

Conclusions:

• Astrocyte metabolic reprogramming and morphological changes occur in specific brain regions affected by MS.
• These findings highlight a potential link between astrocyte metabolism and MS pathophysiology.
• Metabolic reprogramming emerges as a promising novel therapeutic avenue for multiple sclerosis.